Numan Adds Automation To Its Digital Consumer Health Offer With Vi-Health Acquisition
Executive Summary
UK men's health platform Numan continues its mission of disrupting the consumer health industry with its acquisition of Sweden’s Vi-Health technology – a Class I medical device that includes an artificial intelligence-powered symptom checker, as well as advanced e-consultation and workflow automation tools.
You may also be interested in...
MHRA And ASA Pulling Hair Out Over Minoxidil TV Ad Guarantee
The UK's Advertising Standards Agency ruled that an ad for a men's hair loss treatment must not appear again after the Medicines and Healthcare products Regulatory Agency complained that the commercial guaranteed results for users of the drug.
How A UK Tech Start-Up Is Disrupting Men’s Health
HBW Insight talks to Numan's chief medical strategy officer Professor Sam Shah about how the UK tech start-up is bringing innovation to the country's men's health category.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.